The objective of this Administrative Core (Core A) is to support the mission of the University of Pennsylvania (Penn) Alzheimer's Disease (AD) Core Center (ADCC) by facilitating efforts to increase research and understanding of AD and related disorders as well as mild cognitive impairment (MCI) and healthy aging at and beyond Penn. Core A also sets the direction ofthe ADCC, guides development of its programs, promotes interactions of its investigators with National Institute on Aging (NIA) funded AD Centers (ADCs), the National AD Coordinating Center (NACC), the AD Cooperative Study (ADCS), the AD Education and Referral (ADEAR) Center, the AD Neuroimaging Initiative (ADNI), the AD Genetics Consortium (ADGC) and other related NIH and public/private agency supported initiatives focused on AD and related disorders. Core A will accomplish these goals through five highly effective mechanisms. First, Core A provides fiscal and administrative oversight of the ADCC, and the ADCC Executive Committee meets regularly to review ADCC activities and address issues as they arise. Second, Pilot grant applications are solicited annually, and the ADCC Pilot Review Committee identifies 2 meritorious Pilots for funding each year by the ADCC as well as 1-3 additional Pilots funded by the Penn Institute on Aging (lOA) which partners with the ADCC in this Pilot program. Third, Core A organizes annual reviews ofthe Penn ADCC by the ADCC External Advisory Committee. Fourth, Core A facilitates participation of ADCC investigators in annual Penn-wide retreats held by the lOA and the Center for Neurodegenerative Disease Research (CNDR) for students, postdoctoral fellows and faculty from a wide range of disciplines in neuroscience and aging. Finally, Core A promotes interactions of the Penn ADCC with NACC, ADCS, ADEAR, ADNI, ADGC and other ADCs in education and research initiatives. Thus, Core A provides a clearly delineated administrative structure that enables the Penn ADCC to increase the quality and quantity of clinical and basic research as well as educational activities on AD and related disorders as well as MCI and normal aging at and beyond Penn.

Public Health Relevance

; Administrative Core A is highly relevant to the continued success of the Penn ADCC because it exercises fiscal and administrative oversight over this Center, facilitates interactions among ADCC investigators to accomplish the research conducted in programs linked to the Penn ADCC which is the foundational neurodegenerative disease program that has spawned/enabled other neurodegenerative disease research programs at Penn. Finally, Core A coordinates and integrates activities ofthe Cores, and provides mechanisms to advise the Principal Investigator and Core Leaders of this PPG on their progress towards accomplishing the goals of NIA funded ADCCs.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
5P30AG010124-25
Application #
8870236
Study Section
Special Emphasis Panel (ZAG1-ZIJ-5)
Project Start
Project End
Budget Start
2015-07-01
Budget End
2016-06-30
Support Year
25
Fiscal Year
2015
Total Cost
$219,998
Indirect Cost
$82,499
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Goldman, Jennifer G; Andrews, Howard; Amara, Amy et al. (2018) Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease Features. Mov Disord 33:282-288
Lin, Ming; Gong, Pinghua; Yang, Tao et al. (2018) Big Data Analytical Approaches to the NACC Dataset: Aiding Preclinical Trial Enrichment. Alzheimer Dis Assoc Disord 32:18-27
Jansen, Willemijn J; Ossenkoppele, Rik; Tijms, Betty M et al. (2018) Association of Cerebral Amyloid-? Aggregation With Cognitive Functioning in Persons Without Dementia. JAMA Psychiatry 75:84-95
Stites, Shana D; Rubright, Jonathan D; Karlawish, Jason (2018) What features of stigma do the public most commonly attribute to Alzheimer's disease dementia? Results of a survey of the U.S. general public. Alzheimers Dement 14:925-932
Seo, Sang Won; Thibodeau, Marie-Pierre; Perry, David C et al. (2018) Early vs late age at onset frontotemporal dementia and frontotemporal lobar degeneration. Neurology 90:e1047-e1056
Shi, Min; Tang, Lu; Toledo, Jon B et al. (2018) Cerebrospinal fluid ?-synuclein contributes to the differential diagnosis of Alzheimer's disease. Alzheimers Dement 14:1052-1062
Wang, Qi; Guo, Lei; Thompson, Paul M et al. (2018) The Added Value of Diffusion-Weighted MRI-Derived Structural Connectome in Evaluating Mild Cognitive Impairment: A Multi-Cohort Validation1. J Alzheimers Dis 64:149-169
Kirson, Noam Y; Scott Andrews, J; Desai, Urvi et al. (2018) Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease. J Alzheimers Dis 61:295-307
Barnes, Josephine; Bartlett, Jonathan W; Wolk, David A et al. (2018) Disease Course Varies According to Age and Symptom Length in Alzheimer's Disease. J Alzheimers Dis 64:631-642
Zee, Jarcy; Xie, Sharon X (2018) The Kaplan-Meier Method for Estimating and Comparing Proportions in a Randomized Controlled Trial with Dropouts. Biostat Epidemiol 2:23-33

Showing the most recent 10 out of 720 publications